antiepileptic agents
TRANSCRIPT
-
7/30/2019 Antiepileptic Agents
1/23
-
7/30/2019 Antiepileptic Agents
2/23
Known as Anticonvulsants Goal of tx: control or prevent seizures while
maintaining a reasonable quality of life Many patients must take for life Abrupt discontinuation can cause withdrawal
seizures If 1st agent not effective, must be tapered slowly
while 2nd is introduced Depending on agent, therapeutic drug
monitoring of serum levels must be done toassess effectiveness of therapy and avoidtoxicities or under treatment
-
7/30/2019 Antiepileptic Agents
3/23
Classified into
Traditional AED
Newer AED Classes
Barbiturates
Hydantoins Iminostilbenes plus valproic acid
-
7/30/2019 Antiepileptic Agents
4/23
Phenobarbital [generic] oldest Sch IV- B Carbamazepine [Tegretol]- I
Phenytoin [Dilantin]-H Pimidone [Mysoline]-B Valproic acid [Depakene, Depakote,
Depakote ER]-unspecified Exthosuximide [Zarontin]-Succinimide
-
7/30/2019 Antiepileptic Agents
5/23
Gabapentin [Neurontin]-used to treat neuropathicpain also
Lamotrigene [Lamictal]
Levetiracetam [Keppra]-**sleepiness Pregabalin [Lyrica]-Schedule V; also for
neuropathic pain & postherpetic pain Tiagabine [Gabitril] Topiramate [Topamax] Zonisamide [Zonegram] Lacosamide [Vimpat] Banzel [rufinamide] Onfi [Clobazam] 2011 U.S.
-
7/30/2019 Antiepileptic Agents
6/23
-
7/30/2019 Antiepileptic Agents
7/23
Oxacarbazepine-TrileptalGabapentin-NeurontinLamotrigine-LamictalLevetiracetam-Keppra
TopamaxGabitril, Zonegram, pregbalin-Lyrica
-
7/30/2019 Antiepileptic Agents
8/23
1. increase threshold activity in area of braincalled motor cortex
2. limit spread of seizure discharge from itsorigin
3. decrease speed of nerve impulseconduction within a given neuron
-
7/30/2019 Antiepileptic Agents
9/23
Pheno: sedation/drowsiness [most common],lethargy, depression, learning impairment,
physical dependence, poryphyria Valporic acid-hepatoxicity, pancreatitis Phenytoin-gingival hyperplasia,
sedation/drowsiness,nystagmus, diplopia,ataxia, cognitive impairment, skin rash,dyrsrhythmias [IV]
-
7/30/2019 Antiepileptic Agents
10/23
Topiramate [Topamax]-met. Acidosis,hypohidrosis [reduced sweating], close-angleglaucoma
Zonisamide [Zonegram]- nephrolithiasis, psycheffects Pregabalin [Lyrica]-blurred vision, somnolence,
rhabdomyolysis [rare], dependence Lamotrigine [Lamictal]-life threatening rashes-
SJS, toxic epidermal necrolysis Oxcarbazepine [Trileptal]- hyponatremia [less
125 mEq/L], fatal skin rashes, mult-iorganhypersensitivities
-
7/30/2019 Antiepileptic Agents
11/23
Pregnancy: AEDS: teratogenic BUT
Benefits must outweigh the risks Common malformations
Valproic acid-spina bifida & other neural tubedefects
Uncontrolled seizures Safety concern
Induce labor
Injury to baby during last month
-
7/30/2019 Antiepileptic Agents
12/23
Carbamazepine [Tegretol]- Traditional/first generation Uses: partial and general tonic-clonic; trigeminal
neuralgia DO NOT GIVE w/GRAPEFRUIT-increased
toxicity of antiepileptic medication Instruct patient to report visual abnormalities. Instruct patient that abrupt withdrawal after
long-term use may precipitate seizures Must monitor drug levels: 4-12 mcg/mL A/E: bone marrow suppression, fatal aplastic
anemia
-
7/30/2019 Antiepileptic Agents
13/23
1st line drug-Protypical-HYDANTOIN Used: tonic-clonic/partial seizures Most common adverse effects are lethargy, abnormal
movements, mental confusion, and cognitive changes. Gingival hyperplasia is a well-known adverse effect of long-
term oral phenytoin therapy.
Scrupulous dental care can help prevent gingivalhypertrophy.
Long-term=gingival hyperplasia, acne, hirsutism, andhypertrophy of subcutaneous facial tissue resulting in anappearance known as Dilantin facies.
Another long-term consequence of phenytoin therapy is
osteoporosis. Need Vitamin D su lements
-
7/30/2019 Antiepileptic Agents
14/23
Therapeutic drug levels are usually 10 to 20mcg/mL.
Above 20 mcg/mL: Toxic levels: nystagmus,
ataxia, dysarthria, and encephalopathy. Phenytoin can interact with other medications
for two main reasons. First, it is highly bound to plasma proteins and
competes with other highly protein-boundmedications for binding sites.
Second, it induces hepatic microsomal enzymes,mainly cytochrome P-450
-
7/30/2019 Antiepileptic Agents
15/23
Route: PO, IV Should be given slow IVP [not to exceed 50
mg/min in adults] Must be diluted in NORMAL SALINE for IV
infusion & a filter must be used. Follow each dose by saline flush to avoid local
venous irritation Loading dose: 1 gram IV: pt needs to be on a
CARDIAC monitor.
-
7/30/2019 Antiepileptic Agents
16/23
Gingival inflammation
-
7/30/2019 Antiepileptic Agents
17/23
injectable prodrug of phenytoin [Dilantin] Route: intramuscularly or intravenouslyby IV push or
continuous infusionwithout causing burning on injectionFosphenytoin is dosed in phenytoin equivalents (PE)
Fosphenytoin is given at a rate of 150 mg PE/min or less to avoidhypotension or cardiorespiratory depression.
If dysrhythmias or hypotension occur, discontinue the infusion.
Implement fall prevention measures after infusion of either
phenytoin or fosphenytoin because of possible ataxia anddizziness.
Take vital signs up to 2 hours after infusion.
-
7/30/2019 Antiepileptic Agents
18/23
two of the most commonly used antiepilepticdrugs were the barbiturates phenobarbital andprimidone (Mysoline)
Phenobarbital-Schedule IV used for the management of status epilepticus and
is an effective prophylactic drug for the control offebrile seizures
Most common effect: sedation Therapeutic serum drug levels: 10-40 mcg/mL.
Long half-life-50-120 hours
Route: PO, Injectible
-
7/30/2019 Antiepileptic Agents
19/23
Benzodiazepines-Status epilepticus Lorazepam [Ativan]-preferred
Phenytoin [Dilantin] loading 1 gram IV Diazepam [Valium]
Phenobarbital [rarely used]
-
7/30/2019 Antiepileptic Agents
20/23
SAFETY ALERT
During a seizure, you should do the following:
Maintain a patent airway.
Protect the patient's head, turn the patient to the side,loosen constrictive clothing, ease patient to the floor, if
seated.
Do not restrain the patient.
Do not place any objects in the mouth.
-
7/30/2019 Antiepileptic Agents
21/23
When a seizure occurs, you should carefullyobserve and record details of the eventbecause the diagnosis and subsequenttreatment often rest solely on the seizuredescription.
All aspects of the seizure should be noted.
What events preceded the seizure? When didthe seizure occur? How long did each phase(aural [if any], ictal, postictal) last? Whatoccurred during each phase?
-
7/30/2019 Antiepileptic Agents
22/23
Monitor serum drug levels Baseline and periodic lab studies as ordered
O2 as ordered IV access essential Maintain seizure precautions Through neuro/respiratory assessment Instruct patient not to abruptly stop Instruct patient regarding worsening effects Instruct to administer same time each day
-
7/30/2019 Antiepileptic Agents
23/23
IV pump for IV infusions Follow agency protocol for dilantin
Cardiac monitoring as indicated esp.w/dilantin loading [1 gram IV] Instruct to check whether driving is allowed-
most states driving is not allowed for aspecific period of time
All safety precautions